Efficacy of Matrifen in Patients Older Than 18 Years With Severe, Chronic Pain (MATRIX II)
Matrifen for Therapy of Severe, Chronic Pain.
Sponsor: Nycomed
A observational or N/A phase clinical study on Severe, Chronic Pain, this trial is completed. The trial is conducted by Nycomed and has accumulated 8 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Oct 2025 — Present [monthly]
Completed
-
Sep 2025 — Oct 2025 [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
▶ Show 3 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Nov 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Nycomed
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Aachen, Germany , Aalen, Germany , Achim, Germany , Ahaus, Germany , Ahlen, Germany , Aicha, Germany , Albstadt, Germany , Alfeld, Germany , Alfhausen, Germany , Altdorf, Germany and 607 more locations